US Radiopharmaceuticals
Manufacturing · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1389 Center Dr Ste 200, Park City, Utah,...Phone Number
(435) 647-5602Website
www.usradiopharma.usRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About US Radiopharmaceuticals
Founded in 2005, NuView Life Sciences is a clinical-stage precision oncology company located in Park City, Utah.Explore more
US Radiopharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is US Radiopharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
US Radiopharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if US Radiopharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at US Radiopharmaceuticals
Check if US Radiopharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if US Radiopharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when US Radiopharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once US Radiopharmaceuticals has new funding data
Earning: See what the market has to say on US Radiopharmaceuticals recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
US Radiopharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
US Radiopharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about US Radiopharmaceuticals.
US Radiopharmaceuticals financials insights
Gather financial insights about US Radiopharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$90M
US Radiopharmaceuticals News & Media
Oncology Firm Ready to Take Next Step on Non-Invasive Cancer Diagnoses, Treatments
Even as cancer outcomes have improved, many current diagnostic and treatment methods have been around for decades. Utah-based oncology firm NuView Life Sciences is developing a first-of-its-kind peptide analog, NV-VPAC1, which helps eliminate the need for costly, less accurate diagnostic tests and “scorched earth” treatment methods. (PRWeb December 08, 2020) Read the full story at https://www.prweb.com/releases/oncology_firm_ready_to_take_next_step_on_non_invasive_cancer_diagnoses_treatments/prwNuView Life Sciences Develops New Theranostics Approach to Offset High...
The high cost of diagnosing and treating cancer—in addition to the prescription drugs and therapies associated with the disease—is bankrupting hard-working Americans, who cannot afford the expensive... (PRWeb November 16, 2020) Read the full story at https://www.prweb.com/releases/nuview_life_sciences_develops_new_theranostics_approach_to_offset_high_cost_of_cancer_diagnosis_treatment/prweb17547023.htmAlarming Increase in Cancer Fatalities Looms Unless Cancer Screenings...
For fear of contracting COVID-19, a large majority of people are foregoing getting cancer screenings and/or delaying needed testing and care. Doing so could lead to an alarming increase in cancer... (PRWeb October 13, 2020) Read the full story at https://www.prweb.com/releases/alarming_increase_in_cancer_fatalities_looms_unless_cancer_screenings_resume/prweb17465755.htmNuView NV-VPAC1 Uniquely Positioned to Find the Overexpression of Specific Receptors Appearing only on the Surface of Malignant Cells for Early Cancer Diagnosis, Therapy
Cancer diagnosis and treatment need to be improved—and theranostics technology is working to bring a solution to market. NuView Life Sciences is focused on a breakthrough precision theranostic test for cancer, a paired diagnostic and therapeutic protocol which allows physicians to observe the delivery, accuracy, and response of individualized therapy. (PRWeb August 17, 2020) Read the full story at https://www.prweb.com/releases/nuview_nv_vpac1_uniquely_positioned_to_find_the_overexpression_of_sp
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding US Radiopharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2005, NuView Life Sciences is a clinical-stage precision oncology company located in Park City, Utah.... Read More
